Vertex Pharmaceuticals Investors
Vertex Pharmaceuticals is a prominent venture capital fund based in Boston, Massachusetts, established in 1989 The firm specializes in investing in innovative biotechnology companies that focus on transformative therapies With a significant investment scale, Vertex has been instrumental in advancing numerous groundbreaking treatments, particularly in the field of cystic fibrosis The companys strategic approach combines scientific expertise with robust financial backing to drive the development of next-generation therapies Vertex Pharmaceuticals continues to play a pivotal role in shaping the future of healthcare through its commitment to innovation and excellence in biotechnology investments
Investors
%20.jpg)
Connections from
Acquisitions Number:
Made Acquisitions
Founded Date:
1989
Last Funding Type:
Post-IPO Equity
Headquarters:
USA
Investors Number:
9.0
Technology:
Cancer
Employee Number:
1001-5000
Industry:
FemTech
Estimated Revenue:
$500M to $1B
Last Funding Date:
2022-05-17
Number Of Exists:
2
Funding Status:
IPO
Investor Type:
Venture Capital Funds
Investment Stage:
N/A
Total Funding:
656200000.0